Gene · 55143
Papers1,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of immunosuppressive CD4+ T-cell subtype and construction of prognostic model for hepatocellular carcinoma. | Discov Oncol | 2025 | 40996677 | PubTator, text mining | PubMed |
| Plasmodium ARK1 regulates spindle formation during atypical mitosis and forms a divergent chromosomal passenger complex. | bioRxiv | 2025 | 40909691 | PubTator, text mining | PubMed |
| Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis. | Sci Rep | 2025 | 40851084 | PubTator, text mining | PubMed |
| Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer. | Sci Rep | 2025 | 40835666 | PubTator, text mining | PubMed |
| CENcyclopedia: dynamic landscape of kinetochore architecture throughout the cell cycle. | Nat Commun | 2025 | 40825761 | PubTator, text mining | PubMed |
| Transcriptional patterns of cancer-related genes in primary and metastatic tumours revealed by machine learning. | BMC Biol | 2025 | 40775769 | PubTator, text mining | PubMed |
| Development and validation of a hypoxia-immune-based microenvironment gene signature for predicting survival in non-small cell lung cancer. | Discov Oncol | 2025 | 40759816 | PubTator, text mining | PubMed |
| Novel Stemness-Associated Scores: Enhancing Predictions of Hepatocellular Carcinoma Prognosis and Tumor Immune Microenvironment. | Oncol Res | 2025 | 40746880 | PubTator, text mining | PubMed |
| Effect of PGV-1 on Apoptosis via Mitotic Arrest and Senescence in Polyploid Giant Cancer Cells of Hepatocellular Carcinoma JHH4. | Turk J Pharm Sci | 2025 | 40746217 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental studies reveal KPNA2 as a novel biomarker of hepatocellular carcinoma progression and telomere maintenance. | Eur J Med Res | 2025 | 40665355 | PubTator, text mining | PubMed |
| A pivot-tether model for nucleosome recognition by the chromosomal passenger complex. | EMBO Rep | 2025 | 40664717 | PubTator, text mining | PubMed |
| Regulator of chromosome condensation 1 promotes hepatocellular carcinoma proliferation via cell-division-cycle-associated-8 dependent phosphoinositide 3-kinase/protein kinase B signaling. | World J Gastrointest Oncol | 2025 | 40547181 | PubTator, text mining | PubMed |
| Identification of key genes and signaling pathways of liver cancer and model construction for prognosis and diagnosis based on bioinformatics analysis. | PLoS One | 2025 | 40465781 | PubTator, text mining | PubMed |
| Investigating Cisplatin Resistance in Squamous Cervical Cancer: Proteomic Insights into DNA Repair Pathways and Omics-Based Drug Repurposing. | J Proteome Res | 2025 | 40298920 | PubTator, text mining | PubMed |
| Decoding the Role of CDCA Genes in Breast Cancer Progression: Insights From in Silico and Functional Assay. | Asia Pac J Clin Oncol | 2025 | 40245179 | PubTator, text mining | PubMed |
| Multi-Omic Evaluation of PLK1 Inhibitor-Onvansertib-In Colorectal Cancer Spheroids. | J Mass Spectrom | 2025 | 40197665 | PubTator, text mining | PubMed |
| PBK as a novel biomarker performed excellent diagnostic and prognostic value in HCC associated with immune infiltration and methylation. | J Mol Histol | 2025 | 40178670 | PubTator, text mining | PubMed |
| Sustained chromosomal passenger complex activity preserves the pluripotency of human embryonic carcinoma cells. | Sci Signal | 2025 | 40136047 | PubTator, text mining | PubMed |
| Mechanistic insights into CDCA gene family-mediated glioblastoma progression: implications for diagnosis, prognosis, and therapeutic targeting. | Hereditas | 2025 | 40114265 | PubTator, text mining | PubMed |
| CDCA8 and its multifaceted role in tumorigenesis. | Biomed Pharmacother | 2025 | 40056827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55143/papers?page=3